Adma Biologics reported $239.31M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Adma Biologics USD 239.31M 17.22M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Novavax USD 10.01M 1.45M Jun/2026
Omeros USD 712K 266K Sep/2021
Takeda JPY 1.45T 50.64B Jun/2026